Activated PRP for Treatment of Androgenetic Alopecia
Recruiting
A clinical trial to assess the effects and safety of PRP activated with pulsed electrical fields (PEFA-PRP) compared with unactivated PRP when used to treat AGA. The design of this small-scale, phase 1b/2a clinical trial is to demonstrate that pulsed electric field activation of autologous PRP results in a controlled release of platelet growth factors and other biologically active molecules that will have a benefit effect on the non-cycling hair follicles in the treated scalp compared to non-ac... Read More
Gender:
Male
Ages:
Between 30 years and 60 years
Trial Updated:
05/18/2022
Locations: Lahey Hospital and Medical Center, Burlington, Massachusetts
Conditions: Androgenetic Alopecia
Kidney Precision Medicine Project
Recruiting
Acute kidney injury (AKI) and chronic kidney disease (CKD) impose a significant global health burden. Yet, no effective therapies currently exist for AKI, and only a few are available for CKD. Despite significant effort from industry and academia, development of pharmacologic therapies for AKI and CKD has been hampered by: Non-predictive animal models The inability to identify and prioritize human targets The limited availability of human kidney biopsy tissue A poor understanding of AKI and CK... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
05/18/2022
Locations: Yale University, New Haven, Connecticut +7 locations
Conditions: Acute Kidney Failure, Acute Kidney Insufficiency, Acute Renal Failure, Acute Renal Injury, Acute Renal Insufficiency, Kidney Failure, Acute, Kidney Insufficiency, Acute, Renal Failure, Acute, Renal Insufficiency, Acute, Chronic Kidney Diseases, Chronic Kidney Insufficiency, Chronic Renal Diseases, Chronic Renal Insufficiency, Kidney Insufficiency, Chronic
Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy
Recruiting
This study is designed to evaluate the safety and efficacy of dipraglurant in PD patients with dyskinesia (randomized 1:1 to receive active or placebo) for 12 weeks (1 week at 150 mg per day and 11 weeks at 300 mg per day). The primary efficacy assessment will be based on the Unified Dyskinesia Rating Scale (UDysRS). Patients who complete the 12-week blinded treatment period may have the option to roll into an open-label safety extension study for an additional 12-month treatment period.
Gender:
All
Ages:
Between 30 years and 85 years
Trial Updated:
05/18/2022
Locations: Xenosciences Inc, Phoenix, Arizona +40 locations
Conditions: Parkinson Disease, Dyskinesia, Drug-Induced, Dyskinesias
Clinical Specimen Collection From Pompe Disease Patients
Recruiting
Clinical specimens are required from individuals with Pompe Disease to support process and analytical development for a genetically modified autologous bone marrow cell product currently in preclinical research, FTX-PD01. The intent is for this product to be investigated in a subsequent clinical trial under a future FDA IND to treat Pompe Disease. Enrolled participants provide a venous blood specimen (approximately 20mL) to be used in preclinical studies and research and development of FTX-PD01.... Read More
Gender:
All
Ages:
Between 3 years and 30 years
Trial Updated:
05/17/2022
Locations: Seraph Research Institute, Toluca Lake, California
Conditions: Pompe Disease
Efficacy of the ASPEN Intervention Program in Low-Resource Communities
Recruiting
The ASD Screening and Parent ENgagement (ASPEN) program is a culturally adapted, parent-mediated intervention program. The ASPEN program is tailored to address social communication and behavioral difficulties that young children with developmental delays may experience in early childhood. The ASPEN Program includes 12 sessions where parents are provided with psychoeducation about self-care, child development, and evidence-based strategies. Coaching is also provided to train parents on using evid... Read More
Gender:
All
Ages:
Between 18 months and 6 years
Trial Updated:
05/17/2022
Locations: Texas State University, San Marcos, Texas
Conditions: Autism Spectrum Disorder
Using Doxepin for Urticaria
Recruiting
Isolated urticaria in the emergency department is widely treated by physicians with histamine blocking agents such as diphenhydramine, cetirizine, and cimetidine. Doxepin is a tricyclic antidepressant that has been shown to have much higher concentrations of histamine blocking activity and therefore may be useful in treating urticaria. The purpose of this study is to compare the effectiveness of using doxepin verses a traditional medication, diphenhydramine (Benadryl), in the treatment of isolat... Read More
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
05/17/2022
Locations: SUNY Upstate Medical University, Syracuse, New York
Conditions: Urticaria
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
Recruiting
The purpose of this study is to characterize the cortical connectivity changes in the brain of spastic diplegic children after Selective Dorsal Rhizotomy.
Gender:
All
Ages:
Between 3 years and 18 years
Trial Updated:
05/17/2022
Locations: UTHealth & Children's Memorial Hermann Hospital, Houston, Texas
Conditions: Spastic Diplegia
Patient Navigators for Children's Community Mental Health Services in High Poverty Urban Communities
Recruiting
The purpose is to study a model of mental health navigation for African American and Latinx children (5-12 years) in high poverty urban communities focused on reducing key parental attitudinal barriers to care. Reducing persistent racial and ethnic disparities in children's mental health is a national priority and patient navigation is a highly promising approach that is rarely used in children's mental health services. The study will examine the effectiveness of paraprofessional (PP) navigators... Read More
Gender:
All
Ages:
Between 5 years and 12 years
Trial Updated:
05/17/2022
Locations: University of Illinois at Chicago, Chicago, Illinois
Conditions: Community Mental Health Services
Comparative Effectiveness of Bariatric Surgery With PROMs
Recruiting
This long-term, nationwide observational data collection repository will obtain patient-reported outcomes from metabolic and bariatric surgery patients. The data will be used in conjunction with clinical outcomes to determine quality, safety, and comparative effectiveness of various metabolic and bariatric procedures.
Gender:
All
Ages:
0 years and above
Trial Updated:
05/17/2022
Locations: Massachusetts General Hospital, Boston, Massachusetts
Conditions: Bariatric Surgery, Metabolic Surgery, Weight Reduction
Immune Responses to COVID-19 Infection or Vaccination
Recruiting
The overall purpose of this observational cohort study is to characterize COVID-specific immune responses to SARS-CoV-2 exposure or COVID vaccination in a real-world setting. Participants will be asked to provide blood samples (either a normal venous blood draw, a few drops of blood obtained with a small finger-stick device, or both), as well as saliva or nasal swab sample at a series of visits. Subjects will receive results of the testing that is approved for routine clinical use (i.e., their A... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
05/17/2022
Locations: Aditxt, Richmond, Virginia
Conditions: COVID-19
Diffusion Tensor and Functional Connectivity Imaging in Pediatric Epilepsy: Imaging/Histology Correlation
Recruiting
To determine the utility of diffusion tensor magnetic resonance imaging in the preoperative workup of children with intractable epilepsy referred for surgery.
Gender:
All
Ages:
Between 0 days and 18 years
Trial Updated:
05/17/2022
Locations: UTHealth & Children's Memorial Hermann Hospital, Houston, Texas
Conditions: Intractable Epilepsy
Examining the Feasibility of Implementation, Patterns of Association, and Outcomes in HRV Biofeedback (HRVB) Intervention and Music Listening Control (MLC) on Alzheimer's Disease (AD) Family Caregivers (FCGs) Public Title: Caring Relationship Expression Study
Recruiting
In a remotely delivered nationwide pilot study, we will be examining a novel 8-week heart rate variability biofeedback (HRVB) intervention vs music listening control (MLC) for 30 family caregivers 18 years and older (FCGs) of Alzheimer's disease (AD) (and related dementias: ADRD) patients to examine feasibility (acceptability/adherence, satisfaction) and direction of change in caregiver burden, stress, resilience, anxiety, self-compassion, and relationship quality.
Gender:
All
Ages:
18 years and above
Trial Updated:
05/17/2022
Locations: Arizona State University, Phoenix, Arizona
Conditions: Alzheimer's Disease and Related Dementias Family Caregivers